Current Products

Flexible and Customizable Technology

The Ceres Nanotrap technology provides a highly flexible platform that can be customized to meet a variety of diagnostic needs while maintaining its core strengths of concentration and preservation capabilities. Ceres works collaboratively with its end-user customers and channel partners to fully understand their specific needs for diagnostic technologies. In turn, Ceres will either tailor an existing platform particle to meet specific needs, or will develop a new variety of Nanotrap particle as necessary. Our team of scientists can quickly analyze, assess, and match your diagnostic needs to our technology's capabilities.

Currently Under Development: Human Growth Hormone (HGH) Detection

The current focus of Ceres Product Development activities is on the Nanotrap HGH Screening Product. This product will be a reliable and efficient testing medium and process for detecting trace amounts of Human Growth Hormone (HGH) in urine. The HGH Screening Product is a urine-based test for the presence of biomarkers (indicators) of significantly elevated levels of HGH in a test subject. The product will differentiate between naturally produced GH within acceptable ranges and externally administered GH, including natural and synthetic. The HGH urine-based test collection and analysis process will be very similar to current urine-based tests for other substances (not HGH) performed in professional and collegiate athletics.


For more information on current products, planned products, or development opportunities, please contact us at info@ceresnano.com